SCHEMBL4123090

SCHEMBL4123090

COc1cccc(C(O)c2cc(Cl)ccc2NC(=O)O)c1C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 5/20 0.50
KDM4E B2RXH2 4/20 0.45
GAA P10253 2/20 0.45
ALDH1A1 P00352 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GRIK1 P39086 1/20 0.43
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KCNMA1 Q12791 1/20 0.41
HIF1A Q16665 1/20 0.41
LMNA P02545 2/20 0.41
ALOX12 P18054 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4122916 0.91 LPAR1 (0.56) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4125868 0.91 LPAR1 (0.50) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4129998 0.88 LPAR1 (0.48) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4134040 0.88 LPAR1 (0.49) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4119701 0.87 LPAR1 (0.45) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4124875 0.85 LPAR1 (0.45) LPAR1KDM4EGAAALDH1A1NPSR1
SCHEMBL4116747 0.83 LPAR1 (0.45) LPAR1KDM4EALDH1A1NPSR1L3MBTL1
SCHEMBL4125981 0.83 KMT2A (0.42) LPAR1ALDH1A1NPSR1GRIK1MAPT
SCHEMBL4118297 0.83 LPAR1 (0.49) LPAR1ALDH1A1NPSR1L3MBTL1MAPT
SCHEMBL4124228 0.81 LPAR1 (0.43) LPAR1KDM4EGAAALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR LPAR1 345/4885KDM4E 2123/4885GAA 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.